Pursuant to Regulation 47 and 30 read with Para A of Schedule III of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, Medicamen Biotech has informed that it enclosed the Notice of 31st Annual General Meeting (AGM) published in newspapers, ‘The Financial Express (English)’ and ‘Jansatta (Hindi)’ on September 02, 2024.
The above information is a part of company’s filings submitted to BSE.